# American Rebel Holdings Inc: financial statements, quarterly

AREB · OTC · CIK 1648087 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/areb.md) · [Financials](/companies/areb/financials.md) · [Filings](/companies/areb/filings.md) · [Insiders](/companies/areb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/areb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.3](/filings/0001493152-25-005403.md) | [4.6 d](/filings/0001641172-25-003346.md) | [4.0](/filings/0001641172-25-011062.md) | [3.3](/filings/0001641172-25-023267.md) | [2.3](/filings/0001493152-25-021519.md) | [1.8 d](/filings/0001493152-26-014291.md) | [2.5](/filings/0001493152-26-022768.md) | [2.8](/filings/0001493152-26-036917.md) | [1.9](/filings/0001493152-25-021519.md) | [2.3 d](/filings/0001493152-26-014291.md) | [2.0](/filings/0001493152-26-022768.md) | [2.0](/filings/0001493152-26-036917.md) |
| Cost of revenue | $m | [3.1](/filings/0001493152-25-005403.md) | [5.3 d](/filings/0001641172-25-003346.md) | [3.2](/filings/0001641172-25-011062.md) | [3.2](/filings/0001641172-25-023267.md) | [2.8](/filings/0001493152-25-021519.md) | [2.3 d](/filings/0001493152-26-014291.md) | [2.2](/filings/0001493152-26-022768.md) | [2.9](/filings/0001493152-26-036917.md) | [2.1](/filings/0001493152-25-021519.md) | [2.5 d](/filings/0001493152-26-014291.md) | [2.4](/filings/0001493152-26-022768.md) | [2.1](/filings/0001493152-26-036917.md) |
| Gross profit | $m | [0.3](/filings/0001493152-25-005403.md) | [(0.7) d](/filings/0001641172-25-003346.md) | [0.8](/filings/0001641172-25-011062.md) | [0.0](/filings/0001641172-25-023267.md) | [(0.5)](/filings/0001493152-25-021519.md) | [(0.5) d](/filings/0001493152-26-014291.md) | [0.3](/filings/0001493152-26-022768.md) | [(0.0)](/filings/0001493152-26-036917.md) | [(0.2)](/filings/0001493152-25-021519.md) | [(0.3) d](/filings/0001493152-26-014291.md) | [(0.4)](/filings/0001493152-26-022768.md) | [(0.2)](/filings/0001493152-26-036917.md) |
| Research and development | $m | [0.0](/filings/0001493152-25-005403.md) | [0.1 d](/filings/0001641172-25-003346.md) | [0.1](/filings/0001641172-25-011062.md) | [0.3](/filings/0001641172-25-023267.md) | [0.3](/filings/0001493152-25-021519.md) | [(0.3) d](/filings/0001493152-26-014291.md) | [0.1](/filings/0001493152-26-022768.md) | [0.6](/filings/0001493152-26-036917.md) | [0.2](/filings/0001493152-25-021519.md) | [(0.8) d](/filings/0001493152-26-014291.md) | [0.0](/filings/0001493152-26-022768.md) | [0.0](/filings/0001493152-26-036917.md) |
| Operating income | $m | [(2.9)](/filings/0001493152-25-005403.md) | [(4.1) d](/filings/0001641172-25-003346.md) | [(2.3)](/filings/0001641172-25-011062.md) | [(3.9)](/filings/0001641172-25-023267.md) | [(1.0)](/filings/0001493152-25-021519.md) | [(5.0) d](/filings/0001493152-26-014291.md) | [(3.0)](/filings/0001493152-26-022768.md) | [(4.2)](/filings/0001493152-26-036917.md) | [(3.7)](/filings/0001493152-25-021519.md) | [(3.9) d](/filings/0001493152-26-014291.md) | [(4.1)](/filings/0001493152-26-022768.md) | [(4.7)](/filings/0001493152-26-036917.md) |
| Interest expense | $m | [0.1](/filings/0001493152-23-041007.md) | [0.1 d](/filings/0001493152-25-004183.md) | [0.4](/filings/0001493152-24-023852.md) | [1.1](/filings/0001641172-25-023267.md) | [0.6](/filings/0001493152-25-021519.md) | [1.8 d](/filings/0001493152-26-014291.md) | [0.7](/filings/0001493152-26-022768.md) | [0.4](/filings/0001493152-26-036917.md) | [0.3](/filings/0001493152-25-021519.md) | [1.0 d](/filings/0001493152-26-014291.md) | [1.3](/filings/0001493152-26-022768.md) | [0.7](/filings/0001493152-26-036917.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(2.8)](/filings/0001493152-25-005403.md) | [(6.1) d](/filings/0001641172-25-003346.md) | [(2.7)](/filings/0001641172-25-011062.md) | [(5.3)](/filings/0001641172-25-023267.md) | [(1.7)](/filings/0001493152-25-021519.md) | [(7.9) d](/filings/0001493152-26-014291.md) | [(5.1)](/filings/0001493152-26-022768.md) | [(18.1)](/filings/0001493152-26-036917.md) | [(5.2)](/filings/0001493152-25-021519.md) | [(5.9) d](/filings/0001493152-26-014291.md) | [(6.9)](/filings/0001493152-26-022768.md) | [(6.0)](/filings/0001493152-26-036917.md) |
| Diluted EPS | $ per share | [(0.95)](/filings/0001493152-25-005403.md) | not reported | [(27.47)](/filings/0001641172-25-011062.md) | [(201.01)](/filings/0001641172-25-023267.md) | [(3032.24)](/filings/0001493152-25-021519.md) | not reported | [(937997.93)](/filings/0001493152-26-022768.md) | [(213385.21)](/filings/0001493152-26-036917.md) | [(32.44)](/filings/0001493152-25-021519.md) | not reported | [(71.28)](/filings/0001493152-26-022768.md) | [(0.59)](/filings/0001493152-26-036917.md) |
| Basic EPS | $ per share | [(0.95)](/filings/0001493152-25-005403.md) | not reported | [(27.47)](/filings/0001641172-25-011062.md) | [(201.01)](/filings/0001641172-25-023267.md) | [(3032.24)](/filings/0001493152-25-021519.md) | not reported | [(937997.93)](/filings/0001493152-26-022768.md) | [(213385.21)](/filings/0001493152-26-036917.md) | [(32.44)](/filings/0001493152-25-021519.md) | not reported | [(71.28)](/filings/0001493152-26-022768.md) | [(0.59)](/filings/0001493152-26-036917.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.6](/filings/0001493152-23-041007.md) | [1.1](/filings/0001641172-25-003346.md) | [0.7](/filings/0001493152-24-023852.md) | [0.5](/filings/0001493152-24-032142.md) | [0.1](/filings/0001493152-25-005403.md) | [0.3](/filings/0001493152-26-014291.md) | [0.3](/filings/0001641172-25-011062.md) | [0.5](/filings/0001641172-25-023267.md) | [0.7](/filings/0001493152-25-021519.md) | [0.1](/filings/0001493152-26-036917.md) | [0.5](/filings/0001493152-26-022768.md) | [0.1](/filings/0001493152-26-036917.md) |
| Current assets | $m | [13.3](/filings/0001493152-23-041007.md) | [9.4](/filings/0001641172-25-003346.md) | [10.7](/filings/0001493152-24-023852.md) | [9.5](/filings/0001493152-24-032142.md) | [7.4](/filings/0001493152-25-005403.md) | [6.3](/filings/0001493152-26-014291.md) | [6.2](/filings/0001641172-25-011062.md) | [11.6](/filings/0001641172-25-023267.md) | [9.0](/filings/0001493152-25-021519.md) | [5.6](/filings/0001493152-26-036917.md) | [5.5](/filings/0001493152-26-022768.md) | [3.6](/filings/0001493152-26-036917.md) |
| Total assets | $m | [19.5](/filings/0001493152-23-041007.md) | [11.5](/filings/0001641172-25-003346.md) | [14.7](/filings/0001493152-24-023852.md) | [13.2](/filings/0001493152-24-032142.md) | [8.9](/filings/0001493152-25-005403.md) | [10.0](/filings/0001493152-26-014291.md) | [9.7](/filings/0001641172-25-011062.md) | [15.0](/filings/0001641172-25-023267.md) | [31.7](/filings/0001493152-25-021519.md) | [31.8](/filings/0001493152-26-036917.md) | [30.7](/filings/0001493152-26-022768.md) | [27.7](/filings/0001493152-26-036917.md) |
| Current liabilities | $m | [5.9](/filings/0001493152-23-041007.md) | [6.9](/filings/0001641172-25-003346.md) | [8.5](/filings/0001493152-24-023852.md) | [10.1](/filings/0001493152-24-032142.md) | [12.2](/filings/0001493152-25-005403.md) | [15.3](/filings/0001493152-26-014291.md) | [15.6](/filings/0001641172-25-011062.md) | [16.3](/filings/0001641172-25-023267.md) | [26.7](/filings/0001493152-25-021519.md) | [26.0](/filings/0001493152-26-036917.md) | [22.2](/filings/0001493152-26-022768.md) | [23.0](/filings/0001493152-26-036917.md) |
| Total liabilities | $m | [6.4](/filings/0001493152-23-041007.md) | [7.5](/filings/0001641172-25-003346.md) | [9.3](/filings/0001493152-24-023852.md) | [10.6](/filings/0001493152-24-032142.md) | [12.7](/filings/0001493152-25-005403.md) | [17.6](/filings/0001493152-26-014291.md) | [17.7](/filings/0001641172-25-011062.md) | [18.2](/filings/0001641172-25-023267.md) | [28.4](/filings/0001493152-25-021519.md) | [27.4](/filings/0001493152-26-036917.md) | [23.5](/filings/0001493152-26-022768.md) | [24.1](/filings/0001493152-26-036917.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.6](/filings/0001493152-23-041007.md) | [0.6](/filings/0001493152-25-004183.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [1.2](/filings/0001493152-23-041007.md) | [1.9](/filings/0001641172-25-003346.md) | [2.7](/filings/0001493152-24-023852.md) | [3.7](/filings/0001493152-24-032142.md) | [4.4](/filings/0001493152-25-005403.md) | [4.9](/filings/0001493152-26-014291.md) | [4.6](/filings/0001641172-25-011062.md) | [6.9](/filings/0001641172-25-023267.md) | [19.2](/filings/0001493152-25-021519.md) | [19.6](/filings/0001493152-26-036917.md) | [15.3](/filings/0001493152-26-022768.md) | [14.6](/filings/0001493152-26-036917.md) |
| Shareholders' equity | $m | [13.1](/filings/0001493152-25-005403.md) | [4.1](/filings/0001493152-26-014291.md) | [2.5](/filings/0001641172-25-023267.md) | [(1.5)](/filings/0001493152-25-021519.md) | [(3.8)](/filings/0001493152-25-021519.md) | [(7.6)](/filings/0001493152-26-014291.md) | [(8.0)](/filings/0001641172-25-023267.md) | [(3.1)](/filings/0001493152-25-021519.md) | [3.4](/filings/0001493152-25-021519.md) | [4.4](/filings/0001493152-26-014291.md) | [7.2](/filings/0001493152-26-036917.md) | [3.6](/filings/0001493152-26-036917.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,614) d](/filings/0001493152-25-005403.md) | [(942) d](/filings/0001641172-25-003346.md) | [(1,908)](/filings/0001641172-25-011062.md) | [(1,789) d](/filings/0001641172-25-023267.md) | [(1,399) d](/filings/0001493152-25-021519.md) | [(1,922) d](/filings/0001493152-26-014291.md) | [(546)](/filings/0001493152-26-022768.md) | [(2,813) d](/filings/0001493152-26-036917.md) | [(1,610) d](/filings/0001493152-25-021519.md) | [(2,255) d](/filings/0001493152-26-014291.md) | [(1,025)](/filings/0001493152-26-022768.md) | [(1,838) d](/filings/0001493152-26-036917.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | [2.3](/filings/0001493152-26-022768.md) | [40.0 d](/filings/0001493152-26-036917.md) | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.2](/filings/0001493152-23-041007.md) | [0.7](/filings/0001493152-24-023852.md) | [0.7](/filings/0001493152-24-032142.md) | [2.9](/filings/0001493152-25-005403.md) | [0.1](/filings/0001641172-25-011062.md) | [0.0](/filings/0001641172-25-023267.md) | [0.0](/filings/0001493152-25-021519.md) | [0.0](/filings/0001493152-26-022768.md) | [0.0](/filings/0001493152-26-036917.md) | [0.2](/filings/0001493152-25-021519.md) | [0.1](/filings/0001493152-26-022768.md) | [10.1](/filings/0001493152-26-036917.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,489,850 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001493152-26-036917.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.